You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 34 No. 4, April 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (85)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Memory Enhancement After Physostigmine Treatment in the Amnesic Syndrome

Bruce H. Peters, MD; Harvey S. Levin, PhD

Arch Neurol. 1977;34(4):215-219.


Abstract

• Central anticholinergic agents (eg, scopolamine) are known to produce transient memory deficits in human and animal subjects. Damage to the limbic system frequently results from herpes simplex encephalitis (HSE) and produces a memory deficit. If this deficit is due to limbic cholinergic pathway destruction, it might improve with central cholinergic agonists (eg, physostigmine). In a double-blind study over a three-week period, we compared memory performance on three days after 0.8-mg subcutaneous physostigmine therapy (three sessions) to baseline performance and that obtained in three randomly interspersed control sessions. Serial assessment of memory by the Selective Reminding Test showed reproducible enhancement of long-term storage and retrieval with physostigmine treatment. Performance after control injections did not exceed baseline levels. Our findings encourage the hypothesis that cholinergic mechanisms subserve memory and that their pharmacological potentiation might favorably influence some amnesic conditions.



Author Affiliations

From the Departments of Neurology (Dr Peters) and Neurosurgery (Dr Levin) and the Marine Biomedical Institute (Dr Peters), the University of Texas Medical Branch, Galveston, Tex.


Footnotes

Accepted for publication Dec 14, 1976.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Atenolol Compared with Nifedipine: Effect on Cognitive Function and Mood in Elderly Hypertensive Patients
Skinner et al.
ANN INTERN MED 1992;116:615-623.
ABSTRACT  

Glycopyrrolate Versus Atropine in Post-ECT Amnesia in the Elderly
Sommer et al.
J Geriatr Psychiatry Neurol 1989;2:18-21.
ABSTRACT  

Nutritional Biochemistry and Behavioral Disabilities
Fishbein and Meduski
J Learn Disabil 1987;20:505-512.
ABSTRACT  

Effects of Cholinergic Treatment on Posttraumatic Anterograde Amnesia
Goldberg et al.
Arch Neurol 1982;39:581-581.
ABSTRACT  

Botulism and Memory
Haaland and Davis
Arch Neurol 1980;37:657-658.
ABSTRACT  

Cholinomimetics and Memory: The Effect of Choline Chloride
Davis et al.
Arch Neurol 1980;37:49-52.
ABSTRACT  

Effect of Physostigmine on Constructional and Memory Tasks in Alzheimer's Disease
Muramoto et al.
Arch Neurol 1979;36:501-503.
ABSTRACT  

Physostigmine: improvement of long-term memory processes in normal humans
Davis et al.
Science 1978;201:272-274.
ABSTRACT  

Human serial learning: enhancement with arecholine and choline impairment with scopolamine
Sitaram et al.
Science 1978;201:274-276.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.